Dow Up0.76% Nasdaq Up0.69%

Edwards Lifesciences Corp. (EW)

116.76 Up 11.57(11.00%) Oct 24, 4:06PM EDT
|After Hours : 116.00 Down 0.76 (0.65%) Oct 24, 6:34PM EDT
ProfileGet Profile for:
Edwards Lifesciences Corp.
One Edwards Way
Irvine, CA 92614
United States - Map
Phone: 949-250-2500
Fax: 949-250-2525

Index Membership:N/A
Industry:Medical Appliances & Equipment
Full Time Employees:8,600

Business Summary 

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve; and produces pericardial valves from biologically inert animal tissue. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae that is used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient’s heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect patients and clinicians from the risk of infection; and peripheral vascular products used to treat endolumenal occlusive disease, such as balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Edwards Lifesciences Corp.

Corporate Governance 
Edwards Lifesciences Corp.’s ISS Governance QuickScore as of Oct 1, 2014 is 9. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 7; Compensation: 10.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Michael A. Mussallem , 61
Chairman and Chief Exec. Officer
Mr. Donald E. Bobo Jr., 52
Corp. VP of Heart Valve Therapy
Mr. Patrick B. Verguet , 56
Corp. VP of Europe, Middle East & Africa
Mr. Scott B. Ullem , 47
Chief Financial Officer and Corp. VP
Mr. Robert W. A. Sellers ,
Principal Accounting Officer, VP and Corp. Controller
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders